Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00611702 · ClinicalTrials.gov registry record
Genomics of Chronic Renal Allograft Rejection (The GoCAR Study)
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 588
- Enrollment target
NCT00611702 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 588 participants.
The verdict
NCT00611702 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 588 participants
- Enrollment target
Study Summary
Doctors have had success preventing certain types of kidney transplant rejection by suppressing the immune system. However, an individual's genetic make-up and the strength of an immune response to a transplant may also determine whether a transplanted organ is rejected. The purpose of this study is to look at the genetic profile and immune response of people who have had kidney transplants and to correlate the findings with kidney transplant rejection episodes. Donor genetic profiles will also be studied and correlated with the recipient's information.
Interventions
- PROCEDURE Kidney biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 588 participants |
| Start Date | 2008-06 |
| Est. Completion | 2013-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00611702
The ClinicalTrials.gov registry entry for NCT00611702 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 588 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Kidney biopsy is the first listed.
NCT00611702 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00611702 about?
NCT00611702 is a clinical study titled "Genomics of Chronic Renal Allograft Rejection (The GoCAR Study)". Doctors have had success preventing certain types of kidney transplant rejection by suppressing the immune system. However, an individual's genetic make-up and the strength of an immune response to a transplant may also determine whether a transplanted organ is rejected. The purpose of this study is...
What is the current status of trial NCT00611702?
This trial is currently completed. The enrollment target is 588 participants. The study started on 2008-06. Estimated completion is 2013-07.
What interventions are being tested in trial NCT00611702?
The interventions under investigation include: Kidney biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00611702?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.